Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children
Status:
Completed
Trial end date:
2018-09-05
Target enrollment:
Participant gender:
Summary
The overall purpose of this study is to determine if replacing standard soybean oil based fat
emulsions with Omegaven®, a fish oil based fat emulsion, can reverse or prevent the
progression of parenteral nutrition associated liver disease. It is a compassionate use
protocol for patients who already have significant liver disease related to parenteral
nutrition.
Phase:
Phase 2
Details
Lead Sponsor:
Brian Jones, MD
Collaborators:
Children's Hospital & Medical Center Children's Hospital and Medical Center, Omaha, Nebraska University of Nebraska